These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8372684)

  • 81. Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.
    Truffault F; de Montpreville V; Eymard B; Sharshar T; Le Panse R; Berrih-Aknin S
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):108-124. PubMed ID: 27273086
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis.
    Hocaoğlu M; Durmuş H; Özkan B; Yentür SP; Doğan Ö; Parman Y; Deymeer F; Saruhan-Direskeneli G
    J Neuroimmunol; 2018 Oct; 323():36-42. PubMed ID: 30196831
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis.
    Durelli L; Massazza U; Poccardi G; Ferrio MF; Cavallo R; Maggi G; Casadio C; Di Summa M; Bergamini L
    Ann Neurol; 1990 Feb; 27(2):174-80. PubMed ID: 2317013
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.
    Shirai T; Miyata M; Nakase A; Itoh T
    Clin Exp Immunol; 1976 Oct; 26(1):118-23. PubMed ID: 1087211
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Advances in the research on immunopathogenesis of myasthenia gravis].
    Zieliński M; Kuzdzał J; Soja J; Szlubowski A
    Neurol Neurochir Pol; 2003; 37(5):1085-94. PubMed ID: 15174254
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components.
    Haynes BF; Hale LP
    Immunol Res; 1998; 18(2):61-78. PubMed ID: 9844826
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies.
    Gilhus NE; Aarli JA; Matre R
    Acta Neurol Scand; 1983 Nov; 68(5):328-36. PubMed ID: 6364682
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Immune reactivity in patients with myasthenia gravis following removal of the thymus gland].
    Maria A; Márta VS; Beatrix S; Etelka H; László B; Péter G; György P; Gabor B
    Orv Hetil; 1978 Jun; 119(24):1467-70. PubMed ID: 307215
    [No Abstract]   [Full Text] [Related]  

  • 89. Thymic histology in myasthenia gravis.
    Malhotra V; Tatke M; Khanna SK; Gondal R
    Indian J Chest Dis Allied Sci; 1992; 34(3):117-21. PubMed ID: 1302218
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The incidence of thymic B lymphoid follicles in healthy beagle dogs.
    Ploemen JP; Ravesloot WT; van Esch E
    Toxicol Pathol; 2003; 31(2):214-9. PubMed ID: 12696582
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The overexpression of Fra1 disorders the inflammatory cytokine secretion by mTEC of myasthenia gravis thymus.
    Li QR; Ni WP; Lei NJ; Yang JY; Xuan XY; Liu PP; Gong GM; Yan F; Feng YS; Zhao R; Du Y
    Scand J Immunol; 2018 Jul; 88(1):e12676. PubMed ID: 29807388
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Thymic germinal centres in myasthenia gravis: a correlative study.
    Goldstein G
    Clin Exp Immunol; 1967 Jan; 2(1):103-7. PubMed ID: 6030793
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Studies on lymphocyte subsets in thymic tissue and functions of peripheral lymphocytes in patients with tumorous thymus with special reference to myasthenia gravis.
    Tanino M; Koide O; Shimazu A; Suzuki K; Yoshimatsu H
    Acta Pathol Jpn; 1988 Apr; 38(4):425-34. PubMed ID: 3261110
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Modeling the intrathymic pathogenesis of myasthenia gravis.
    Levinson AI
    J Neurol Sci; 2013 Oct; 333(1-2):60-7. PubMed ID: 23332143
    [TBL] [Abstract][Full Text] [Related]  

  • 95. In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis.
    Vincent A; Scadding GK; Thomas HC; Newsom-Davis J
    Lancet; 1978 Feb; 1(8059):305-7. PubMed ID: 75339
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Lymphocyte subsets in normal human lymphoid tissues.
    Hsu SM; Cossman J; Jaffe ES
    Am J Clin Pathol; 1983 Jul; 80(1):21-30. PubMed ID: 6190394
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Development of the thymus and immune system].
    Matsui N; Nitta T; Takahama Y
    Brain Nerve; 2011 Jul; 63(7):679-84. PubMed ID: 21747137
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Over-expression of CCL21 up-regulates the antigen presentation-related genes of CK8/18 positive thymic epithelial cells in patients with myasthenia gravis].
    Zhang Y; Zhao J; Zhu Z; Yin T; Xuan X; Liu P; Li Q; DU Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):957-60. PubMed ID: 26146068
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals.
    Yi Q; Ahlberg R; Pirskanen R; Lefvert AK
    Neurology; 1992 May; 42(5):1081-4. PubMed ID: 1374547
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components.
    Haynes BF; Hale LP
    Immunol Res; 1998; 18(3):175-92. PubMed ID: 9951649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.